You are hereF&D
They aim at earning the reputation of being a reliable manufacturer and a force to reckon with in the area of Production of Chemical Intermediates, Bulk Actives and Pharmaceutical Formulations. They aim at being considered a benchmark when it comes to Production efficiency & excellence across the Globe. They see ourselves in the future as contributing to the success of our customers.
Kemwell Pvt Ltd., established in the year 1972 at Bangalore, Specializes in contract manufacturing for pharmaceutical formulations for various reputed multinations in India. For its expansion plans is looking for yound dynamic personnel.
Post: Manager - Formulation, R&D, QA
Fresher M.Pharm, M.Sc, B.Pharm, B.Sc invited for Marketing Executives, Marketing Managers, Formulation Development in Olefia Biopharma - more than 100 vacancies
Olefia Biopharma Limited, We would like to introduce ourselves as one of the most rapidly emerging FMCG Company in various fields of Pharmaceutical, Cosmetics, Ayurvedics / herbals and biotech.
Olefia Biopharma Limited is utilising MHRA and WHO-GMP Approved manufacturing unit to manufacture various Tablets, Capsule, Syrups, Suspensions and other formulations for its various division viz. Pharmaceutical and Cosmetic i.e. FMCG and exporting to various countries across the Globe.
The National Dairy Development Board (NDDB) set up Indian Immunologicals Ltd. (IIL) in 1982 with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price. The technology for FMD vaccine manufacture was obtained from M/s. Wellcome Foundation Limited, United Kingdom. The plant in Hyderabad today has a capacity to make 80 million trivalent doses of FMD vaccine. Following the successful introduction of Foot &Mouth Disease Vaccine-Raksha, IIL launched the tissue culture vaccine "Raksharab" in 1989. This was the first Indian tissue culture vaccine in the market.
Career in La renon Healthcare as Research Associate (QA) & Senior Scientist/ Research Associate (F&D)
"La Renon" is created out of passion to become a global healthcare company by offering World-class quality pharmaceutical products and services for various critical illnesses and diseases.
"La Renon" is founded and managed by a group of professionals of varied domains of healthcare industry itself who have got vast experience with unmatched expertise to achieve the above said objective. The company's focus is on continuous value addition to its business model, to make it an unparallel platform for their every stakeholder.
YASWANTH ALLAMNENI1*, NAVYA ALLAMNENI2, R AMARNATH1, T RAMASWAMY CHOWDARY1, V SATYANARAYANA1, K VENKATESWARA RAO1
1Research and Development Department, Natco Pharma Limited, Kothur, Mahaboobnagar, Andhra Pradesh – 509228.
2Department of Pharmaceutical Technology, Narasaraopeta Institute of Pharmaceutical Sciences, Narasaraopeta, Guntur,
Andhra Pradesh, India.
The main aim of this article was to review the development of ODTs, challenges in formulation, new ODT technologies and evaluation methodologies, suitability of drug candidates, and future prospects.Over the past three decades, orally disintegrating tablets (ODTs) have gained considerable attention as a preferred alternative to conventional tablets and capsules due to better patient compliance. ODTs are solid dosage forms containing medicinal substances which disintegrate rapidly, usually in a matter of seconds, when placed on the tongue. Orally disintegrating tablets are also called as orodispersible, quick disintegrating, mouth dissolving, fast disintegrating, rapid dissolving tablets, porous tablets, and rapimelts.Orally disintegrating systems have carved a niche amongst the oral drug delivery systems due to the highest component of compliance they enjoy in patients especially the geriatrics and pediatrics. However, of all the above terms, USP approved these dosage forms as ODTs. These tablets are distinguished from conventional sublingual tablets, lozenges, and buccal tablets which require more than a minute to dissolve in the mouth. According to the recently issued draft guidance for Industry of orally disintegrating tablets, FDA specifically recommends that, in addition to the original definition for an ODT, ODTs be considered solid oral preparations that disintegrate rapidly in the oral cavity, with an in vitro disintegration time of approximately 30 sec or less according to the united states pharmacopoeia (USP) disintegration method or alternative. ODTs release drug in the mouth for absorption through local oromucosal tissues and through pregastric (e.g., oral cavity, pharynx, and oesophagus), gastric (i.e., stomach) and post gastric (e.g. .small and large intestines) segments of the gastrointestinal tract.
Multiple vacancies in AKUMS DRUGS & PHARMACEUTICALS | Require B.Pharm, M.Pharm, B.Sc, M.Sc in DRA, QA, AR&D, FR&D, IPR, stores and more
AKUMS DRUGS & PHARMACEUTICALS LTD is one of the most innovative, productive and research based pioneer organization of India having its registered office at Delhi and various plants in Haridwar, Uttrakhand giving employment to more than 2000 people.
More M.Pharm / M.Sc Freshers invited as Associate Scientist - Analytical in Novartis | Fresher - 3 posts
A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.